# Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency

> **NCT00191360** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 68 (—)

## Conditions studied

- Adult Growth Hormone Deficiency

## Interventions

- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT00191360
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 68 (—)
- **Last updated:** 2007-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00191360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00191360, "Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00191360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*